Albany Molecular Research, Inc. (AMRI) has entered into a two-year natural products-based drug discovery collaboration with Bristol-Myers Squibb. Under the terms of the agreement, AMRI will test samples from its natural product hit seeking collections against multiple drug targets in a range of therapeutic areas. AMRI may provide follow-up medicinal chemistry hit-to-lead optimization, biocatalysis or chemical synthesis support on compounds of interest to BMS. The collaboration includes an u...